Invention Grant
- Patent Title: Polynucleotide enrichment using CRISPR-Cas systems
-
Application No.: US14804068Application Date: 2015-07-20
-
Publication No.: US10457969B2Publication Date: 2019-10-29
- Inventor: Gordon M. Cann , Jeffrey G. Mandell , Alex Aravanis , Steven Norberg , Dmitry K. Pokholok , Frank J. Steemers , Farnaz Absalan , Leila Bazargan
- Applicant: Illumina, Inc.
- Applicant Address: US CA San Diego
- Assignee: Illumina, Inc.
- Current Assignee: Illumina, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Gavrilovich, Dodd & Lindsey LLP
- Main IPC: C12P19/34
- IPC: C12P19/34 ; C12N15/10 ; C12Q1/6816 ; C12Q1/683 ; C12Q1/6869

Abstract:
A method for enriching a target nucleic acid comprising providing an endonuclease system having a crRNA or a derivative thereof, and a Cas protein or a variant thereof. The crRNA or the derivative thereof contains a target-specific nucleotide region substantially complementary to a region of the target nucleic acid; contacting the target nucleic acid with the endonuclease system to form a complex; and separating the complex and thereby enriching for the target nucleic acid.
Public/Granted literature
- US20160017396A1 POLYNUCLEOTIDE ENRICHMENT USING CRISPR-CAS SYSTEMS Public/Granted day:2016-01-21
Information query